Protein Kinase Signaling in the Genotoxic Stress Response
Protein Kinase Signaling in the Genotoxic Stress Response
批准号:
9975171
负责人:
MICHAEL B YAFFE
金额:
$54.05万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-01 至 2025-07-31
关键词:
Antineoplastic AgentsApoptosisBindingCell DeathCellsCellular StressCytokine SignalingDNA DamageData SetDevelopmentEnvironmental ExposureEnvironmental HealthEpithelialEpithelial CellsEpitheliumExposure toGene ExpressionGenetic TranscriptionGenotoxic StressGoalsHumanImpairmentIncidenceInflammationInflammatoryLaboratoriesMAP Kinase GeneMAPKAPK2 geneMalignant NeoplasmsMediatingMediator of activation proteinModelingPathway interactionsPatientsPhosphoserinePlayProductionProtein KinaseRNARNA-Binding ProteinsRoleSignal PathwaySignal TransductionStimulusStressTP53 geneThreonineTissuesToxinXenobioticsbiological adaptation to stresscancer preventioncell injurycytokineflexibilityimprovedin vivo evaluationinterestmouse modelneoplastic cellnovelp38 Mitogen Activated Protein Kinaseprotein functionresponsetherapeutic targettumortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary: The long-term goal of our laboratory is to understand how specific protein kinase signaling
pathways function together with phosphoserine/threonine-binding domains and RNA binding proteins (RNA-
BPs) to regulate tumor development after exposure to inflammation and genotoxic stress. We are particularly
interested in understanding how these pathways can be manipulated to enhance cancer prevention, as well as
to improve the response of any tumors that do form to conventional anti-cancer agents. In addition to the two
canonical DNA damage response pathways that cells use to respond to DNA damage, the ATR-Chk1 pathway,
and the ATM-Chk2 pathway, we recently identified a third DNA damage response pathway mediated by
p38MAPK and MAPKAP Kinase-2 (MK2) that is absolutely essential for p53-defective tumor cells to survive
after genotoxic stress. Importantly, the MK2 pathway is dispensable in cells with intact p53 function, making it
an ideal target for specifically impairing the ability of cells undergoing cancer transformation to survive
additional DNA damage. Unlike the ATR-Chk1 and ATM-Chk2 pathways that are dedicated to responding
solely to signals from DNA damage, the p38 MAPK-MK2 pathway is a global stress-response pathway
activated by multiple types of cellular stress, and plays a critical role in cytokine production during inflammation
and early tumor development. Thus, we believe that the p38MAPK-MK2 pathway plays a particularly novel role
during oncogenesis following genotoxic stress by integrating DNA damage response pathways within the
damaged cells with inflammation and cytokine signaling arising in the adjacent stromal microenvironment.
Importantly, both the DNA damage response function, and the cytokine production function of MK2, as well as
many of the activities controlled by ATM-Chk2 and ATR-Chk1, appear to be mediated, in large part, by the
action of RNA-BPs, which control gene expression at the post-transcriptional level. Finally, we and others have
observed that certain xenobiotics appear to cause cell injury and death not through DNA damage, but instead
through a distinct RNA damage response that has been very poorly characterized to date.
In this proposal we (1) investigate the role of MK2 signaling in both the epithelial compartment and the
inflammatory microenvironment in murine models of genotoxic stress-induced cancer development; (2)
elucidate the emerging roles of RNA-binding proteins as key mediators of the cellular response to DNA
damage; and (3) explore a poorly understood RNA damage response that induces profound apoptosis in a
wide variety of epithelial tissues. The flexibility afforded by R-35 mechanism allows us to pursue these
questions using a wide variety of combined experimental and computational approaches. The resulting
mechanistic models are then tested in vivo using murine models of environmental stress-induced cancer and
by querying human patient derived datasets, in order to achieve a transformational impact in the environmental
health sciences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:10219250
-
项目类别:
-
资助金额:$53.21万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:10664948
-
项目类别:
-
资助金额:$51.45万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:9752562
-
项目类别:
-
资助金额:$54.86万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling in the Genotoxic Stress Response
-
批准号:10445249
-
项目类别:
-
资助金额:$52.34万
-
财政年份:2017
-
负责人:MICHAEL B YAFFE
-
依托单位:
Biopolymers & Proteomics
-
批准号:9149768
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2015
-
负责人:MICHAEL B YAFFE
-
依托单位:
Phospho-Binding Ligands and Substrates of BRCA1
-
批准号:8413981
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2012
-
负责人:MICHAEL B YAFFE
-
依托单位:
Phospho-Binding Ligands and Substrates of BRCA1
-
批准号:8502497
-
项目类别:
-
资助金额:$19.66万
-
财政年份:2012
-
负责人:MICHAEL B YAFFE
-
依托单位:
Biopolymers & Proteomics
-
批准号:8181146
-
项目类别:
-
资助金额:$21.46万
-
财政年份:2010
-
负责人:MICHAEL B YAFFE
-
依托单位:
DNA Damage Networks
-
批准号:8181035
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2010
-
负责人:MICHAEL B YAFFE
-
依托单位:
Neutrophil Priming in Trauma and Sepsis
-
批准号:7933278
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2009
-
负责人:MICHAEL B YAFFE
-
依托单位:
STRUCTURE OF THE SIGMA ISOFORM OF THE PHOSPHOPEPTIDE-BINDING PROTEIN 14-3-3
-
批准号:7721199
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2008
-
负责人:MICHAEL B YAFFE
-
依托单位:
PROJECT 7
-
批准号:7695173
-
项目类别:
-
资助金额:$18.85万
-
财政年份:2008
-
负责人:MICHAEL B YAFFE
-
依托单位:
Cell Growth & Proliferation Gordon Research Conference
-
批准号:7332061
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:MICHAEL B YAFFE
-
依托单位:
Cell Growth & Proliferation Gordon Research Conference
-
批准号:7452423
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2007
-
负责人:MICHAEL B YAFFE
-
依托单位:
CORE--BIOPOLYMER LABORATORY
-
批准号:7552760
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2007
-
负责人:MICHAEL B YAFFE
-
依托单位:
Cell Growth & Proliferation Gordon Research Conference
-
批准号:7846140
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling and Cell Cycle Control
-
批准号:8583727
-
项目类别:
-
资助金额:$50.33万
-
财政年份:2006
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling and Cell Cycle Control
-
批准号:8719102
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2006
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling and Cell Cycle Control
-
批准号:7190433
-
项目类别:
-
资助金额:$36.05万
-
财政年份:2006
-
负责人:MICHAEL B YAFFE
-
依托单位:
Protein Kinase Signaling and Cell Cycle Control
-
批准号:8856565
-
项目类别:
-
资助金额:$50.33万
-
财政年份:2006
-
负责人:MICHAEL B YAFFE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: